Lumexa Imaging Holdings (LMRI) risk factors, FY2025 10-K

Risks Related to Our Business and Our Industry

1. 01Our ability to generate revenue depends in large part on referrals from physicians and other healthcare providers
2. 02Because many of our costs are fixed, lower scan volumes or other decreases to revenues could adversely affect the profitability of our business
3. 03Our ability to maintain and attract new business depends upon the quality of our services, our reputation and the reputations of our radiologists, joint venture partners and the third-party providers with whom we contract
4. 04If our contracted radiology practices terminate their agreements with us, our business could be negatively impacted
5. 05We are dependent on our and our contracted radiology practices’ ability to hire and retain qualified radiologists and radiologic technologists, as well as our ability to hire and retain key personnel
6. 06Our labor costs have been, and we expect they will continue to be, adversely affected by competition for staffing, the nationwide shortage of radiologists and experienced and skilled healthcare professionals and regulatory activity, including changes in minimum wage laws
7. 07higher labor costs. If prevailing wages continue to be driven higher, we could suffer increased employee turnover and increased costs, adversely affecting our business
8. 08Our joint ventures depend on existing relationships with key health system partners. If we are unable to maintain synergistic relationships with these health systems, or enter into new relationships with health systems, we may be unable to implement our business strategies successfully
9. 09Adverse changes in general domestic and worldwide economic conditions could adversely affect our business, financial condition, results of operations, liquidity and stock price
10. 10We experience competition from other diagnostic imaging companies, hospitals and physician’s practices, and this competition could adversely affect our revenue and business
11. 11If reimbursement rates paid by third-party governmental or commercial payors are reduced or if we fail to successfully manage the reimbursement and collections processes, our business, financial condition, results of operations, liquidity and stock price could be harmed
12. 12Additionally, fluctuations in state-determined Medicaid reimbursement rates, which historically reimburse at a lower rate than Medicare (such as those caused by the One Big Beautiful Bill Act), may further negatively impact our business
13. 13In addition, certain of our services may require patients to pay out-of-pocket fees. Our ability to collect these out-of-pocket fees is subject to various coverage and reimbursement policies of third-party payors that may change over time and may be open to a variety of interpretations and applications
14. 14There are risks associated with our current and potential future use of AI
15. 15Hospitals may terminate their agreements with us, modify the types or reduce the volume of services requested or reduce fees paid to us
16. 16We may be unable to effectively maintain our equipment or generate revenue when our equipment is not operational or being upgraded
17. 17A disruption to the availability of medical equipment could cause a loss of revenue, which could adversely affect our business, financial condition, results of operations, liquidity and stock price
18. 18Technological change in our industry could reduce the demand for our services and require us to incur significant costs to upgrade our equipment
19. 19We may become subject to professional malpractice liability and other litigation claims, which could be costly and negatively impact our reputation and business
20. 20If we are unable to obtain insurance, or if insurance becomes more costly for us to obtain, our business may be adversely affected
21. 21insurers or reinsurers are unable or unwilling to insure us or the industry at historical premiums and coverage levels
22. 22Business interruptions due to natural disasters, including floods, fires, hurricanes and severe winter storms or other external events beyond our control, can adversely affect our business, financial condition, results of operations, liquidity and stock price
23. 23Consolidation in the healthcare industry could adversely affect our business, financial condition, results of operations, liquidity and stock price
24. 24We may not be able to successfully complete acquisitions or enter into new joint ventures on acceptable terms, which may slow our growth rate
25. 25We may face risks with respect to our expansion strategy of opening de novo centers
26. 26A restriction in our ability to make capital expenditures would restrict our growth and could adversely affect our business
27. 27We may fail to realize all of the anticipated benefits of our past and any future acquisitions, or those benefits may take longer to realize than expected. We may also encounter significant difficulties in integrating these acquired businesses into our operations
28. 28Our debt obligations could expose us to risks that could materially adversely affect our liquidity and financial condition
29. 29limiting our ability to borrow additional cash, make investments and incur liens
30. 30We may be required to recognize an impairment of our goodwill, other intangible assets, or other long-lived assets, which could have an adverse effect on our business, financial condition, and results of operations, liquidity and stock price
31. 31Our business exhibits seasonal fluctuations that could cause significant fluctuation in our quarterly operating results, which could increase the volatility of our stock price and cause losses to our stockholders
32. 32Cybersecurity threats and other disruption or malfunctions in our information technology systems could adversely affect our business
33. 33acts of vandalism or theft, misplaced or lost data, programming or human errors and similar events
34. 34Actual or perceived failures to comply with applicable data protection, privacy and security laws, regulations, standards and other requirements could adversely affect our business, financial condition, results of operations, liquidity and stock price
35. 35The regulatory framework in which we operate is uncertain and continually evolving and complying with federal and state regulations is an expensive and time-consuming process
36. 36federal and state environmental and health and safety laws
37. 37If we fail to comply with various licensure, certification and accreditation standards, we may be subject to loss of licensure, certification or accreditation, which would adversely affect our operations
38. 38State efforts to regulate the construction or expansion of healthcare facilities could impair our ability to operate and expand our operations
39. 39Some of our imaging modalities use radioactive materials, which generate regulated waste and could subject us to liabilities for injuries or violations of environmental and health and safety laws
40. 40Government authorities or other parties may assert that our business practices violate antitrust laws

Risks Relating to the Ownership Our Common Stock

1. 41An active trading market for our common stock may not be sustained, and you may not be able to resell your shares of our common stock at or above the initial offering price you paid
2. 42Our operating results and share price may be volatile
3. 43other events or factors, including those from natural disasters, war, acts of terrorism or responses to these events
4. 44If our operating and financial performance in any given period does not meet the guidance that we provide to the public, the price of our common stock may decline
5. 45If securities or industry analysts do not publish research or publish misleading or unfavorable research about our business, our share price and trading volume may decline
6. 46We do not intend to pay cash dividends for the foreseeable future, and accordingly, stockholders must rely on stock appreciation for any return on their investment
7. 47We will continue to incur significant costs as a result of operating as a public company
8. 48The accuracy of our financial statements and related disclosures could be affected if the judgments, assumptions or estimates used in our critical accounting policies are inaccurate
9. 49program development controls to ensure that new software development is tested, authorized and implemented appropriately
10. 50Our failure to maintain effective internal controls over financial reporting could have an adverse impact on us
11. 51We are an “emerging growth company” and our election of reduced reporting requirements applicable to emerging growth companies may make our common stock less attractive to investors
12. 52exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved
13. 53WCAS and management own a significant percentage of our common stock and will be able to exert significant control over matters subject to stockholder approval and their interests may conflict with your interests as an owner of our common stock
14. 54Certain of our directors may have conflicts of interest because of their ownership of equity interests of, and their employment with, WCAS and its affiliates
15. 55Our amended and restated certificate of incorporation contains exclusive forum provisions that may limit our stockholders’ ability to obtain a favorable judicial forum for disputes with us or our directors, stockholders, officers or other employees
16. 56Our amended and restated certificate of incorporation contains a provision renouncing our interest and expectancy in certain corporate opportunities
17. 57Some provisions of Delaware law and our governing documents could discourage a takeover that stockholders may consider favorable